Abevmy 100mg |Bevacizumab (Mylan)| MHP
ABEVMY 100MG/4ML METASTATIC COLON DESCRIPTION Bevacizumab is a drug sold under the name of Abevmy 100mg and which is categorized as monoclonal anti-body & anti-angiogenesis When Abevmy 100mg concomitant use with human monoclonal antibody IgG1, that circumstance and prohibits the biological action of human vascular endothelial growth factor (VEGF). USAGE Abevmy 100mg is indicated for the treatment of some of the conditions like : Metastatic colon or rectal cancer Non-squamous, non-small cell lung cancer Glioblastoma Metastatic renal cell cancer Metastatic cervical cancer Epithelial ovarian, fallopian tube or peritoneal cancer. MECHANISM OF ACTION Abevmy 100mg injection comprises an active compound like Bevacizumab which binds to VEGF and avoid the communication of VEGF to its receptors like Flt-1 & KDR) present on the surface of the cells This interaction prevents endothelial cell multiplication and new blood vessel produ...